Chicago Atlantic BDC, Inc.
LIENAnalytical Summary
Chicago Atlantic BDC, Inc. shows mixed fundamentals. Further due diligence is recommended before making investment decisions.
19-Year Financial Trajectory
QuarterlyHealth Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) |
12.1%
Fair
↓
Fair
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-45.5%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
81.0%
Excellent
↓
Excellent
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
312.5%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
65.0%
Excellent
↑
Excellent
Improving
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M |
10.5%
Fair
↓
Fair
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-78.9%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
— |
122.2%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
533.3%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | — | — | — | — | — | — |
| Net Income Growth YoY (%) |
12.1%
Fair
Fair
Year-over-year change in net income |
3.4%
Caution
Caution
Year-over-year change in net income |
N/M | N/M | N/M |
24.4%
Good
Good
Year-over-year change in net income |
34.9%
Excellent
Excellent
Year-over-year change in net income |
N/M | N/M | — | N/M |
472.1%
Excellent
Excellent
Year-over-year change in net income |
-97.2%
Weak
Weak
Year-over-year change in net income |
— | — | — | — | — | — |
| FCF Growth YoY (%) |
-186.7%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | N/M | — | — | — | N/M | — | — | — |
-190.2%
Weak
Weak
Year-over-year change in free cash flow |
— | — | — | — | — | — |
| EPS CAGR 3Y (%) |
-0.9%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
— |
63.0%
Excellent
Excellent
Compound annual EPS growth over 3 years |
133.1%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-2.44x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-1.67x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.16x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.23x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.95x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.92x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
-2.03x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.11x
Fair
Fair
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
-1.10x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
0.78x
Caution
↑
Caution
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-114.05x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.01x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Capital (%) (%) | — | — | — | — | — | — |
-1.9%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
-0.3%
Weak
↑
Weak
Improving
Operating profit relative to total assets
Optimal:
> 10%
|
-1.1%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
— |
-3.0%
Weak
↓
Weak
Declining
Operating profit relative to total assets
Optimal:
> 10%
|
1.3%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
2.6%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — | — |
| Return on Common Equity (%) (%) |
2.8%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.7%
Weak
→
Weak
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.9%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.8%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.5%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.6%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-2.1%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-0.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-1.2%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
7.5%
Caution
↑
Caution
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-3.0%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
1.3%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
2.7%
Weak
↑
Weak
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
0.7%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
0.2%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Debt (USD) | $-3.35M | $-2.93M | $-10.46M | $-13.83M | — | $-23.93M | $-30.11M | $-34.00M | $-33.16M | — | $-29.82M | $-32.90M | $-32.54M | $-35.13M | — | — | — | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Equity (USD) | $304.18M | $303.41M | $302.92M | $301.84M | $301.02M | $301.16M | $82.54M | $84.26M | $84.52M | $85.55M | $87.40M | $90.04M | $88.83M | $86.48M | $85.32M | $84.76M | $-507.55K | $84.55M | $-159.72K |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-K ↗ | Q3 FY2025 Sep 30, 2025 10-Q ↗ | Q2 FY2025 Jun 30, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-K ↗ | Q3 FY2024 Sep 30, 2024 10-Q ↗ | Q2 FY2024 Jun 30, 2024 10-Q ↗ | Q1 FY2024 Mar 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 10-K ↗ | Q3 FY2023 Sep 30, 2023 10-Q ↗ | Q2 FY2023 Jun 30, 2023 10-Q ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 10-K ↗ | Q3 FY2022 Sep 30, 2022 10-Q ↗ | Q2 FY2022 Jun 30, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Mar 31, 2022 10-K ↗ | Q4 FY2020 Mar 31, 2021 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $8.54M | $8.25M | $8.83M | $8.58M | $7.61M | $7.97M | $-1.72M | $-260.69K | $-1.03M | $6.41M | $-2.64M | $1.21M | $2.36M | — | $559.92K | $211.74K | $85.06M | — | — |
| Operating Cash Flow (USD) | $-20.83M | $-13.77M | $-1.39M | $1.95M | $-7.26M | $-7.33M | — | — | $2.10M | $7.14M | — | — | $-2.58M | — | $437.40K | $-24.15M | $-509.11K | — | — |
Secondary lens
Benchmark Lens
Compare LIEN against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare LIEN against peers after checking the statement evidence.
Percentile Rankings
How LIEN compares to all companies
Compare LIEN with peers
Stack LIEN against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 6 years · 19 quarters